NCT06939088View on ClinicalTrials.gov

Effects of Tirzepatide on Alcohol Intake in Patients Diagnosed With Schizophrenia and Alcohol Use Disorder

PHASE2RecruitingINTERVENTIONAL
Enrollment

108

Participants

Timeline

Start Date

May 5, 2025

Primary Completion Date

August 1, 2028

Study Completion Date

December 31, 2028

Conditions
Alcohol Use DisorderAlcohol Abuse/DependenceAlcohol DependenceAlcoholismSchizophrenia DisordersSchizophrenia and Disorders With Psychotic FeaturesSchizophrenia and Schizophrenia Spectrum PsychosisSchizophrenia
Interventions
DRUG

Tirzepatide

Once weekly injections s.c. with tirzepatide (Mounjaro(R))

DRUG

Placebo

Once weekly injections s.c. with placebo (BD Posiflush)

Trial Locations (2)

2100

RECRUITING

Psychiatric Center Copenhagen, Frederiksberg Hospital, Frederiksberg

9000

NOT_YET_RECRUITING

Department of Psychiatry, Aalborg University Hospital, Aalborg

All Listed Sponsors
lead

Anders Fink-Jensen, MD, DMSci

OTHER